MediWound Statistics
Total Valuation
MediWound has a market cap or net worth of $167.62 million. The enterprise value is $134.52 million.
| Market Cap | 167.62M |
| Enterprise Value | 134.52M |
Important Dates
The next estimated earnings date is Tuesday, May 28, 2024, before market open.
| Earnings Date | May 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MediWound has 9.49 million shares outstanding.
| Shares Outstanding | 9.49M |
| Owned by Insiders (%) | 25.73% |
| Owned by Institutions (%) | 34.41% |
| Float | 5.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.97 |
| Forward PS | 6.84 |
| PB Ratio | 5.31 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.27.
| Current Ratio | 4.59 |
| Quick Ratio | 4.35 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.45 |
Financial Efficiency
Return on equity (ROE) is -20.20% and return on invested capital (ROIC) is -38.03%.
| Return on Equity (ROE) | -20.20% |
| Return on Assets (ROA) | -10.10% |
| Return on Capital (ROIC) | -38.03% |
| Revenue Per Employee | $186,860 |
| Profits Per Employee | -$67,160 |
| Employee Count | 100 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 6.28 |
Taxes
In the past 12 months, MediWound has paid $185,000 in taxes.
| Income Tax | 185,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.03% in the last 52 weeks. The beta is 0.93, so MediWound's price volatility has been similar to the market average.
| Beta (1Y) | 0.93 |
| 52-Week Price Change | +49.03% |
| 50-Day Moving Average | 15.32 |
| 200-Day Moving Average | 11.10 |
| Relative Strength Index (RSI) | 61.65 |
| Average Volume (30 Days) | 72,519 |
Short Selling Information
| Short Interest | 171,631 |
| Short Previous Month | 162,648 |
| Short % of Shares Out | 2.16% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.85 |
Income Statement
In the last 12 months, MediWound had revenue of $18.69 million and -$6.72 million in losses. Loss per share was -$0.75.
| Revenue | 18.69M |
| Gross Profit | 3.58M |
| Operating Income | -15.29M |
| Pretax Income | -6.53M |
| Net Income | -6.72M |
| EBITDA | -3.34M |
| EBIT | -4.64M |
| Loss Per Share | -$0.75 |
Balance Sheet
The company has $41.71 million in cash and $8.61 million in debt, giving a net cash position of $33.10 million or $3.49 per share.
| Cash & Cash Equivalents | 41.71M |
| Total Debt | 8.61M |
| Net Cash | 33.10M |
| Net Cash Per Share | $3.49 |
| Equity / Book Value | 31.60M |
| Book Value Per Share | 3.33 |
| Working Capital | 38.87M |
Cash Flow
In the last 12 months, operating cash flow was -$10.47 million and capital expenditures -$6.46 million, giving a free cash flow of -$16.93 million.
| Operating Cash Flow | -10.47M |
| Capital Expenditures | -6.46M |
| Free Cash Flow | -16.93M |
| FCF Per Share | -$1.88 |
Margins
Gross margin is 19.15%, with operating and profit margins of -81.83% and -35.94%.
| Gross Margin | 19.15% |
| Operating Margin | -81.83% |
| Pretax Margin | -34.95% |
| Profit Margin | -35.94% |
| EBITDA Margin | -17.85% |
| EBIT Margin | -24.83% |
| FCF Margin | -90.60% |
Dividends & Yields
MediWound does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.73% |
| Shareholder Yield | -80.73% |
| Earnings Yield | -4.01% |
| FCF Yield | -10.10% |
Analyst Forecast
The average price target for MediWound is $32.00, which is 81.20% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $32.00 |
| Price Target Difference | 81.20% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 49.95% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 20, 2022. It was a reverse split with a ratio of 1:7.
| Last Split Date | Dec 20, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:7 |
Scores
MediWound has an Altman Z-Score of -0.05 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.05 |
| Piotroski F-Score | 1 |